Stomach Cancer Awareness Month 2026: When Persistent Stomach Problems Need Medical Attention

Stomach problems are common, and most are linked to everyday issues such as indigestion, acidity or a temporary infection. But when symptoms such as persistent upper abdominal discomfort, frequent indigestion, unexplained weight loss, loss of appetite, nausea or feeling full after eating only a small amount keep returning or do not improve, they should not be ignored.

Stomach Cancer Awareness Month 2026 is an opportunity to understand which symptoms deserve closer attention, who may be at higher risk of stomach cancer and why timely medical evaluation matters. In this blog, we’ll look at the possible warning signs of stomach cancer, its risk factors and when ongoing stomach problems should prompt a visit to a doctor.

What is Stomach Cancer Awareness Month and Why Does It Matter?

Stomach Cancer Awareness Month is observed every November to improve understanding of stomach or gastric cancer, its warning signs, risk factors, prevention and early detection.

The observance gained formal recognition in the United States in 2010 after advocacy by No Stomach For Cancer led to a U.S. Senate resolution designating November as Stomach Cancer Awareness Month. Since then, awareness efforts have expanded internationally, encouraging people to understand their family history, recognise possible symptoms and support those affected by the disease.

For India, the conversation is particularly relevant. According to GLOBOCAN 2022 estimates, India recorded 64,611 new stomach cancer cases and 57,727 deaths due to the disease. Stomach cancer ranked seventh by new cases and sixth by cancer deaths overall. Among Indian men, it was the fifth most commonly diagnosed cancer, with an estimated 43,060 new cases.

These numbers do not mean that every episode of stomach discomfort should cause alarm. Rather, the purpose of awareness is to help people recognise when persistent or unexplained symptoms deserve a closer look.

Why Can Stomach Cancer Be Easy to Miss Early?

Stomach cancer can be challenging to identify in its earlier stages for several reasons:

• There may be no obvious symptoms at first: Early stomach cancer may produce few or no noticeable changes.
• Symptoms can resemble common digestive problems: Indigestion, heartburn, mild nausea, bloating and stomach discomfort can occur with many non-cancerous conditions.
• Symptoms alone cannot confirm the cause: The same complaint can result from gastritis, reflux, ulcers, infections and several other gastrointestinal problems.
• There is no routine screening test for everyone: People without symptoms and at average risk are not routinely screened for stomach cancer in many healthcare settings.

Early stomach cancer can be difficult to recognise because there may be little to distinguish it from more common stomach conditions at first. Symptoms alone cannot confirm the cause, and there is no routine screening programme for everyone at average risk.

What are the Warning Signs of Stomach Cancer?

Stomach cancer symptoms can vary depending on the location and extent of the disease. Possible warning signs include:

• Persistent indigestion, heartburn or stomach discomfort
• Feeling bloated after eating
• Feeling unusually full after eating a small amount
• Persistent nausea
• Loss of appetite
• Unexplained weight loss
• Persistent upper abdominal pain
• Recurrent vomiting
• Blood in vomit
• Blood in the stool or black, tarry stools
• Difficulty swallowing
• Unexplained weakness or fatigue, which may sometimes be related to anaemia

When Does Acidity or Indigestion Need More Attention?

An occasional episode of acidity, bloating or indigestion after eating is common. What deserves attention is a change from your usual pattern.

Speak with a doctor if stomach symptoms:

• Keep returning or do not improve as expected
• Become progressively worse
• Are accompanied by unexplained weight loss or appetite loss
• Make you feel full after eating unusually small amounts
• Occur with persistent vomiting
• Are accompanied by difficulty swallowing
• Occur with black stools or blood in vomit

You do not need to wait for severe pain before seeking advice. Persistent or unexplained changes can be evaluated to find the cause, whether it turns out to be cancer or a much more common digestive condition.

Who is More at Risk of Stomach Cancer?

Having a risk factor does not mean that you will develop stomach cancer. Many people with risk factors never develop the disease, and some people diagnosed with stomach cancer have no identifiable risk factor.

Several factors, however, are associated with a higher risk, such as:

H. pylori Infection

Long-term infection with H. pylori, a bacterium that lives in the stomach lining, is a major risk factor for gastric cancer. Chronic infection can cause inflammation and, in some people, progressive changes in the stomach lining.

Certain Stomach and Medical Conditions

Risk can also be higher in people with conditions such as:

• Chronic atrophic gastritis
• Intestinal metaplasia
• Pernicious anaemia
• Certain gastric polyps
• A history of partial stomach removal

Family History and Inherited Cancer Syndromes

Having a first-degree relative, such as a parent, sibling or child, with stomach cancer can increase risk.

Certain inherited conditions are also associated with increased risk, including hereditary diffuse gastric cancer (HDGC), Lynch syndrome, familial adenomatous polyposis and other recognised hereditary cancer syndromes.

Age, Tobacco and Diet

The risk of stomach cancer generally increases with age. Tobacco use also raises risk.

Dietary patterns may contribute as well. Diets high in salted, smoked or poorly preserved foods and low in fruits and vegetables have been associated with increased stomach cancer risk. Excess body weight is particularly relevant to cancers affecting the upper part of the stomach.

What is the Link Between H. pylori and Stomach Cancer?

Having H. pylori does not mean that you have stomach cancer. In fact, many people infected with the bacterium never develop cancer.

The concern is with long-term infection. H. pylori can cause chronic inflammation of the stomach lining. In some people, this can lead to atrophic gastritis and further cellular changes that increase the likelihood of gastric adenocarcinoma.

Research has consistently linked an increased risk of stomach cancer, particularly cancers arising in the main part of the stomach. Importantly, studies also show that treating H. pylori infection can reduce the risk of gastric cancer.

Whether you need testing for H. pylori depends on your symptoms, medical history and individual risk. A doctor can recommend appropriate testing and treatment where required.

Should Everyone Be Screened for Stomach Cancer?

No. People at average risk of stomach cancer do not usually need routine screening.

Screening means checking for cancer before any symptoms appear. Whether screening is recommended depends on a person’s risk factors and, in some countries, how common stomach cancer is in the population.

People who have a higher-than-average risk may be advised to have regular monitoring with tests such as an upper GI endoscopy. This may include selected people with:

• Chronic gastric atrophy or pernicious anaemia
• A strong family history of stomach cancer
• Certain inherited genetic syndromes
• A previous partial gastrectomy
• Other recognised high-risk stomach conditions

According to the National Cancer Institute (NCI) there is no standard routine screening test for people at average risk of stomach cancer. However, upper gastrointestinal (GI) endoscopy may be considered for selected people who have a higher risk of developing the disease.

Screening is Different from Investigating Symptoms

It is important to understand that screening and diagnostic testing are not the same thing.

Screening is done in people who do not have symptoms, usually because they belong to a higher-risk group.

Diagnostic evaluation is done when someone already has symptoms, an abnormal test result or another finding that needs further investigation.

So, even if routine stomach cancer screening is not recommended for everyone, persistent or concerning symptoms should still be assessed by a doctor. Depending on the situation, this may involve tests such as an upper GI endoscopy.

How is Stomach Cancer Diagnosed?

If stomach cancer is suspected, doctors first try to determine whether the symptoms are due to cancer or another condition.

Evaluation may begin with a review of symptoms, medical and family history, physical examination and blood tests. Blood tests can help identify problems such as anaemia, while stool testing may detect hidden bleeding.

Upper GI Endoscopy and Biopsy

Upper gastrointestinal endoscopy with biopsy is a key test for diagnosing stomach cancer.

During endoscopy, a thin flexible tube with a camera is passed through the mouth so the doctor can examine the oesophagus and stomach. If an abnormal area is found, tissue samples can be taken for examination under a microscope.

At RGCIRC, upper GI endoscopy with biopsy is used as part of the diagnostic evaluation for suspected stomach cancer.

Tests After a Diagnosis

If stomach cancer is confirmed, additional tests help determine how far it has spread and guide treatment planning. Depending on the individual case, these may include:

• CT scan: Helps assess the stomach, nearby lymph nodes and other organs for signs of spread.
• Endoscopic ultrasound (EUS): Helps evaluate how deeply the tumour has grown into the stomach wall and nearby structures.
• PET-CT: May be used in selected cases to look for cancer activity elsewhere in the body.
• Pathology and biomarker testing: Provides more detailed information about the tumour and may help guide treatment decisions.

Why Does Multidisciplinary Care Matter After a Stomach Cancer Diagnosis?

A stomach cancer diagnosis does not automatically lead to the same treatment for everyone.

The treatment team needs to consider:

• Where the tumour is located
• How deeply it has grown into the stomach wall
• Whether lymph nodes are involved
• Whether cancer has spread elsewhere
• Whether the tumour can be removed surgically
• Pathology and relevant biomarker findings
• The patient’s nutritional status and overall health

At Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), gastrointestinal cancers are managed through a multidisciplinary team involving GI Oncosurgeons, medical oncologists, radiation oncologists, gastroenterologists, radiologists, nuclear medicine specialists and GI pathologists, among other specialists according to individual needs.

Complex GI and hepatopancreatobiliary cases are discussed in a weekly multidisciplinary tumour board, allowing different specialists to contribute to the treatment strategy.

This becomes especially important in stomach cancer because the sequence of surgery, systemic therapy and other treatments can vary significantly from one patient to another.

How is Stomach Cancer Treated?

Treatment depends on the type and stage of cancer, its location, whether it has spread and the patient’s general health.

Endoscopic Treatment for Selected Early Cancers

Some very early stomach cancers confined to the superficial layers may be treated endoscopically instead of requiring major surgery.

RGCIRC offers endoscopic mucosal resection for appropriately selected early stomach cancers.

Surgery

Surgery is an important part of treatment for many localised stomach cancers. Depending on the tumour, part of the stomach (subtotal gastrectomy) or the entire stomach (total gastrectomy) may need to be removed along with appropriate lymph nodes.

For gastric cancer, RGCIRC’s GI Oncosurgery unit offers:

• D2 subtotal or total gastrectomy
• Laparoscopic D2 subtotal or total gastrectomy
• Robotic gastrectomy

Systemic Treatment

Chemotherapy may be given before or after surgery or used to treat advanced disease.

For selected cancers, targeted therapy or immunotherapy may also become part of treatment depending on the tumour’s molecular and biomarker characteristics.

Radiation Therapy

Radiation therapy may be considered in selected situations depending on the stage, previous treatment and overall treatment plan.

The most appropriate approach is determined after considering the complete clinical picture rather than one test or tumour feature in isolation.

What Can You Do During Stomach Cancer Awareness Month?

Awareness is most useful when it leads to informed action. This November, you can:

• Learn which persistent digestive changes deserve medical attention.
• Know whether stomach cancer or related cancers occur in your family.
• Discuss a significant family history with your doctor.
• Ask about H. pylori testing if your symptoms or medical history make it relevant.
• Avoid tobacco.
• Limit excessive intake of heavily salted, smoked and poorly preserved foods.
• Choose a balanced diet that includes fruits and vegetables.
• Avoid repeatedly self-treating persistent stomach symptoms without understanding their cause.
• Share reliable, medically reviewed information rather than frightening or unverified cancer claims.

The aim is not to become anxious about every episode of indigestion. It is to recognise when a symptom is persistent, unusual for you or accompanied by other concerning changes.

When Should You Speak to a Doctor?

Consider medical evaluation if you have stomach or digestive symptoms that repeatedly return, continue despite appropriate treatment or gradually become worse.

Speak with a doctor if you develop symptoms such as:

• Unexplained weight loss
• Persistent appetite loss
• Feeling unusually full after small meals
• Recurrent or persistent vomiting
• Difficulty swallowing
• Ongoing stomach pain or indigestion
• Unexplained fatigue or anaemia
• Blood in vomit or black, tarry stools

Vomiting blood or passing black, tarry stools can indicate gastrointestinal bleeding and requires prompt medical attention, particularly if accompanied by weakness, dizziness or fainting.

These symptoms do not automatically mean stomach cancer. The purpose of medical evaluation is to identify the actual cause and determine whether further tests, including endoscopy, are needed.

Paying Attention Does Not Mean Expecting the Worst

Most stomach problems are not caused by cancer. Acidity, indigestion, nausea and bloating are common symptoms with many possible explanations.

Stomach Cancer Awareness Month is a reminder not to fear every stomach symptom, but also not to normalise a problem that keeps returning, worsening or changing. Knowing your risk factors and seeking timely medical advice when something does not seem right can help you get the appropriate evaluation sooner.

At RGCIRC, patients with suspected or diagnosed stomach cancer have access to multidisciplinary evaluation and treatment is planned according to the stage and characteristics of the cancer, overall health and individual needs.

If you or a family member has been diagnosed with stomach cancer, has a suspicious stomach finding or needs a specialist opinion, consult the stomach cancer team at RGCIRC for further evaluation and personalised treatment planning. Call +91-11-47022222 to book an appointment.

Frequently Asked Questions

1. Can a stomach ulcer turn into stomach cancer?

Most peptic ulcers do not simply turn into stomach cancer. However, H. pylori infection can cause peptic ulcers and is also an established risk factor for stomach cancer. Some stomach cancers can also initially resemble an ulcer during endoscopy. Persistent or suspicious gastric ulcers may therefore require endoscopic assessment and biopsy to establish the correct diagnosis.

2. Can stomach cancer run in families?

Yes, although most stomach cancers are not caused solely by inherited genetic conditions. Risk can be higher if a first-degree relative has had stomach cancer or if the family carries certain inherited cancer syndromes, including hereditary diffuse gastric cancer. People with a strong family history may benefit from genetic counselling and an individual risk assessment.

3. Can anaemia be a sign of stomach cancer?

It can be. Slow bleeding from the stomach may lead to iron-deficiency anaemia, which can cause fatigue, weakness, breathlessness or paleness. However, anaemia has many possible causes and does not by itself indicate stomach cancer. Doctors may recommend further investigation based on the type of anaemia, symptoms and other findings.

4. Can someone live normally after part or all of the stomach is removed?

Many people adapt to life after partial or total gastrectomy, but eating habits usually need to change. Smaller, more frequent meals, nutritional monitoring and vitamin or mineral supplementation may be required depending on the operation. Recovery and long-term nutritional needs vary, so follow-up with the cancer and nutrition teams is important.

5. Which specialists treat stomach cancer at RGCIRC?

Stomach cancer treatment at RGCIRC may involve GI oncosurgeons, medical oncologists, radiation oncologists, gastroenterologists, radiologists, nuclear medicine specialists and GI pathologists, depending on the case. Complex GI cancers can also be reviewed through RGCIRC’s weekly multidisciplinary GI and HPB tumour board.

6. Does RGCIRC offer robotic surgery for stomach cancer?

Yes. RGCIRC’s GI Oncosurgery unit offers robotic gastrectomy as well as laparoscopic and open approaches for gastric cancer. Whether robotic or another surgical approach is suitable depends on the tumour, disease extent, previous treatment and the patient’s overall health.

7. Can very early stomach cancer be treated without major stomach surgery at RGCIRC?

Yes, selected very early stomach cancers may be suitable for an endoscopic procedure instead of gastrectomy. At RGCIRC, we offer endoscopic mucosal resection for appropriately selected early stomach cancers.

Whether this approach is suitable depends on factors such as the tumour’s size, depth and pathological features. Our specialists assess these factors before recommending the most appropriate treatment.

8. Does RGCIRC offer treatment for stomach cancer that has spread to the peritoneum?

RGCIRC offers cytoreductive surgery (CRS) and HIPEC for selected gastric cancers with peritoneal metastases. This approach is not appropriate for every patient with metastatic stomach cancer. Suitability requires careful assessment of the disease extent, overall health, previous treatment and likely benefit through a multidisciplinary team.